[1]
Suhardi, K.F. et al. 2025. Empagliflozin for liver and lipid profile in metabolic dysfunction-associated fatty liver disease: a meta-analysis. Medical Journal of Indonesia. 34, 4 (Nov. 2025), 268–77. DOI:https://doi.org/10.13181/mji.oa.257855.